Packaged Astaxanthin was Cyanotech’s largest product and service line in fiscal 2025, bringing in $13.15M of $24.22M (54%).
| Product and Service | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natural Astaxanthin Products Bio Astin | — | — | — | — | ||||||||||
| Packaged Astaxanthin | $14.93M | $12.23M | $13.61M | $13.15M | ||||||||||
| Spirulina Products | — | — | — | — | ||||||||||
| Packaged Spirulina | $7.60M | $4.81M | $5.78M | $5.22M | ||||||||||
| Bulk Spirulina | $10.39M | $3.54M | $1.57M | $2.41M | ||||||||||
| Bulk Astaxanthin | $2.45M | $1.98M | $1.49M | $2.59M | ||||||||||
| Contract Extraction & Rd Services | $600.00K | $614.00K | $616.00K | $849.00K | ||||||||||
| Contract Extraction | — | — | — | — | ||||||||||
| Other Products | — | — | — | — | ||||||||||
| Total | $35.97M | $23.18M | $23.07M | $24.22M |
Cyanotech brought in $24.22M from its five product and service lines in fiscal 2025, the year ended March 31, 2025. That was up 5.0% from $23.07M in fiscal 2024. Packaged Astaxanthin was the largest at $13.15M (54.3%), ahead of Packaged Spirulina at $5.22M (21.6%) and Bulk Astaxanthin at $2.59M (10.7%). The other two lines brought in $3.25M combined.
Compared with fiscal 2024, Bulk Astaxanthin grew fastest, up 73.9% to $2.59M, while Packaged Spirulina fell the most, down 9.6% to $5.22M. From fiscal 2022 to 2025, combined revenue from these lines fell from $35.97M to $24.22M, a compound annual decline of 12.4%. Packaged Astaxanthin's share of the total rose from 41.5% to 54.3%.
United States was Cyanotech’s largest region in fiscal 2025, bringing in $19.05M of $24.22M (79%).
| Geography | FY 2012 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $24.47M | $17.03M | $18.89M | $19.05M | |||||||||
| Asia Pacific | $7.10M | $2.16M | $1.25M | $1.06M | |||||||||
| Europe | $3.18M | $2.44M | $1.60M | $2.64M | |||||||||
| Other Countries | $1.22M | $1.54M | $1.34M | $1.47M | |||||||||
| Total | $35.97M | $23.18M | $23.07M | $24.22M |
Cyanotech brought in $24.22M from its four regions in fiscal 2025, the year ended March 31, 2025. That was up 5.0% from $23.07M in fiscal 2024. United States was the largest at $19.05M (78.7%), ahead of Europe at $2.64M (10.9%) and Other Countries at $1.47M (6.0%). The remaining region, Asia Pacific, brought in $1.06M.
Compared with fiscal 2024, Europe grew fastest, up 65.3% to $2.64M, while Asia Pacific fell the most, down 14.9% to $1.06M. From fiscal 2022 to 2025, combined revenue from these regions fell from $35.97M to $24.22M, a compound annual decline of 12.4%. United States' share of the total rose from 68.0% to 78.7%.
Scenario, Previously Reported was Cyanotech’s largest revenue line in fiscal 2014, bringing in $24.97M of $25.26M (99%).
| Scenario | FY 2013 | FY 2013 | FY 2013 | FY 2013 | FY 2014 | FY 2014 | FY 2014 |
|---|---|---|---|---|---|---|---|
| Scenario, Previously Reported | $27.58M | $6.91M | $7.30M | $21.65M | $7.44M | $8.68M | $24.97M |
| Restatement Adjustment | -$122.00K | -$504.00K | $54.00K | -$37.00K | $182.00K | -$738.00K | $293.00K |
| Total | $27.46M | $6.41M | $7.35M | $21.61M | $7.62M | $7.95M | $25.26M |
Cyanotech brought in $25.26M from its two revenue lines in fiscal 2014, the year ended December 31, 2014. That was up 217.9% from $7.95M in fiscal 2014. Scenario, Previously Reported was the largest at $24.97M (98.8%), ahead of Restatement Adjustment at $293.00K (1.2%).
Cyanotech (CYAN) reports its revenue by product and service, by geography and by scenario. In fiscal 2025, Packaged Astaxanthin was its largest product and service line, bringing in $13.15M (54.3% of the total), followed by Packaged Spirulina at $5.22M (21.6%).
Packaged Astaxanthin was Cyanotech's largest product and service line in fiscal 2025, bringing in $13.15M, or 54.3% of the $24.22M total across its five product and service lines.
United States was Cyanotech's largest region in fiscal 2025, bringing in $19.05M, or 78.7% of the $24.22M total across its four regions.
Scenario, Previously Reported was Cyanotech's largest revenue line in fiscal 2014, bringing in $24.97M, or 98.8% of the $25.26M total across its two revenue lines.
Among Cyanotech's product and service lines that make up at least 2% of revenue, Bulk Astaxanthin grew fastest in fiscal 2025, up 73.9% from $1.49M to $2.59M.
Every figure comes from Cyanotech's annual financial filings, as reported. Each line keeps the name Cyanotech gives it, and years follow its fiscal calendar.
Cyanotech's revenue by product and service goes back to fiscal 2012, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.